mesalamine has been researched along with Eye Diseases in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Eye Diseases: Diseases affecting the eye.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, FM | 1 |
| Vavricka, SR | 1 |
| den Broeder, AA | 1 |
| de Jong, EM | 1 |
| Hoentjen, F | 1 |
| van Dop, WA | 1 |
| Cury, DB | 1 |
| Moss, AC | 1 |
1 review available for mesalamine and Eye Diseases
| Article | Year |
|---|---|
Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; | 2020 |
1 other study available for mesalamine and Eye Diseases
| Article | Year |
|---|---|
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; A | 2010 |